Research
Micronutrients & recovery
Inhibition of ceramide biosynthesis improves hepatic steatosis (fatty liver) in obese mice, associated with reduced hepatic SOCS-3 expression.
Blocking ceramide production reduces fatty liver in obese mice, likely by lowering SOCS-3 levels.
GoodSupportsHIGH confidence
Hematoxylin and eosin staining showed pronounced steatosis with macrovesicular fat accumulation in obese mice... which was significantly reduced after myriocin treatment... hepatic triglycerides... were also reduced in myriocin-treated obese mice... myriocin treatment resulted in significant reductions in hepatic SOCS-3 expression in the DIO models.
Why this rating
Consistent findings across obese mouse models.
Source
Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome
Guang Yang et al. · American Journal of Physiology-Endocrinology and Metabolism · 2009
mechanism_onlyCited 294×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →